Actively Recruiting

Phase Not Applicable
Age: 15Years - 70Years
All Genders
NCT05906056

Continuous Passive Motion Versus Heterotopic Ossification

Led by University of Ioannina · Updated on 2024-12-06

20

Participants Needed

1

Research Sites

201 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The investigators hypothesize that Heterotopic Ossification (HO) formation can be suppressed if the application of a Continuous Passive Motion (CPM) device can be performed for a substantial amount of time. The investigators will use the following study design: a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study. The comparison between the treatment and referent groups of the outcomes will prove the prophylactic power of CPM against HO.

CONDITIONS

Official Title

Continuous Passive Motion Versus Heterotopic Ossification

Who Can Participate

Age: 15Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with stabilized medical condition suffering from neurological insult either traumatic brain injury (TBI), stroke, or Spinal Cord Injury
  • Negative triplex ultrasound to rule out deep venous thrombosis (DVT)
  • Positive three-phase bone scan with Tc99 upon onset of HO symptoms
  • Verified HO formation on the knee or hip joint confirmed by CT scan
Not Eligible

You will not qualify if you...

  • Life-threatening conditions making Continuous Passive Motion (CPM) application difficult
  • HO detected in locations other than the hip or knee joint
  • Presence of other fractures interfering with bone alkaline phosphatase (AP) levels
  • Patients not responding to painful stimuli

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Physical and Rehabilitation Medicine

Ioannina, Epirus, Greece, 45110

Actively Recruiting

Loading map...

Research Team

A

Avraam Ploumis, MD, PhD

CONTACT

G

George I Vasileiadis, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here